Return On Equity ratio Analysis of Merrimack Pharmaceuticals Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY ROE
Period Ending - Dec-23
Very Poor ROE
-7.64
Period Ending - Dec-22
Very Poor ROE
-8.02
Growth
4.71 %
Trailing Twelve Months ROE
Period Ending - Dec-23
Excellent ROE
337.01
Most recent Quarter ROE
Period Ending - Mar-24
Excellent ROE
90.85
ROE Analysis of Merrimack Pharmaceuticals Inc
| ROE Ratio of Merrimack Pharmaceuticals Inc with value of 337.01 means its generates profits efficiently by using its Shareholders Fund. |
| ROE Ratio of Merrimack Pharmaceuticals Inc with value of 90.85 means its generates profits efficiently by using its Shareholders Fund in latest Quarter ending on Mar-24. |
| ROE Ratio of MACK has grown by 4.71 % Compared to previous Financial Year. |
| ROE Ratio of MACK trending up for at least three Years. |
| ROE Ratio with value of -100.12 was lowest in Year Dec-19 in last Five Years. |
| Latest ROE Ratio with value of -7.64 is Greater than Average ROE of -30.40 in last five years. |
| ROE of Merrimack Pharmaceuticals Inc is negative because of poor net profit in FY ended on Dec-23. |
Other ROE Related Info of MACK that may interest you.
Merrimack Pharmaceuticals Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| MACK | 15.13 | 15.13 | 0 % | Biotechnology |
Defination of Return On Equity
The Return on Equity (ROE) is a profitability metric that measures a company's ability to generate profits using its shareholder's fund. ROE is calculated by dividing Net Income by Shareholders' Fund. more ..
ROE Related Ratios
| ReturnOnAsset | NetProfitMargin |
Tsr Profitability Index
| No Significant Profitability | |
FY - Historical Return On Equity of Merrimack Pharmaceuticals Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| ROE | -7.64 | -8.02 | -17.30 | -18.92 | -100.12 | -68.87 | 490.25 |
| Change | 4.71 % | 53.64 % | 8.53 % | 81.10 % | -45.38 % | -114.05 % |
FY Chart of Return On Equity of Merrimack Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)